A study to determine gut microbiome-derived uremic toxin levels of sevelamer carbonate and sucroferric oxyhydroxide, and their association with gut microbiome-derived gut microbiome-derived uremic toxin levels in hemodialysis patients
Latest Information Update: 22 Aug 2022
At a glance
- Drugs Sevelamer (Primary) ; Sucroferric oxyhydroxide (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
Most Recent Events
- 22 Aug 2022 New trial record